O-14 - COVID-19 Therapies

Co-Author(s)

• JA

  Joshua Abata, BS

  Medical Student
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Jose Arribas, MD

  Head of the Infectious Diseases Unit and Research Director of HIV and Infectious Diseases
  Hospital Universitario La Paz
  Madrid, Madrid, Spain

  Disclosure: NO DISCLOSURE DATA
• RB

  Rima Bachour, MD

  Hospitalist
  MedStar Southern Maryland Hospital
  Clinton, Maryland

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• EB

  Enos Bernasconi, MD

  Investigator
  Servizio Malattie infettive, Ente Ospedaliero Cantonale, Ospedale
  Ticino, Luzern, Switzerland

  Disclosure: Gilead Sciences Inc. (Scientific Research Study Investigator)
• CB

  Christiana Blair, MS

  Director
  Biostatistics
  Gilead Sciences Inc.
  Foster City, California

  Disclosure: NO DISCLOSURE DATA
• 

  Diana Brainard, MD

  SVP, Therapeutic Area Head, Virology
  Clinical Research - HIV
  Gilead Sciences Inc.
  Foster City, CA

  Disclosure: Gilead Sciences : Employee
• MB

  Michael Brown, MD

  Consultant Physician and Clinical Lead at the Hospital for Tropical Diseases
  University College Hospital
  London, England, United Kingdom

  Disclosure: Gilead Sciences Inc. (Scientific Research Study Investigator)
• HC

  Huyen Cao, MD

  Sr Director, Virology Clinical Research
  Gilead Sciences Inc.
  Foster City, California

  Disclosure: Gilead Sciences Inc. (Employee, Shareholder)
• AC

  Anna Maria Cattelan, MD

  Investigator
  UOC Malattie Infettive e Tropicali, Azienda Ospedaliera di Padova
  Padova, Puglia, Italy

  Disclosure: NO DISCLOSURE DATA
• YC

  Yao-Shen Chen, MD

  Investigator
  Kaohsiung Veterans General Hospital
  Kaohsiung, Kaohsiung

  Disclosure: NO DISCLOSURE DATA
• DC

  David Chien Boon Lye, MD

  Investigator
  National Centre for Infectious Diseases, Tan Tock Seng Hospital
  Singapore, Singapore

  Disclosure: NO DISCLOSURE DATA
• BC

  Bum Sik Chin, MD

  Investigator
  National Medical Center
  Seoul, California

  Disclosure: NO DISCLOSURE DATA
• AC

  Anand Chokkalingam, PhD

  Clinical Research
  Gilead
  Foster City, California

  Disclosure: NO DISCLOSURE DATA
• 

  Vineet Chopra, MD, MSc

  Chief, Division of Hospital Medicine
  Michigan Medicine
  Ann Arbor, Michigan

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AC

  Alexandra Coritsidis, BS

  Medical Student
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• GC

  Gerard Criner, MD

  Critical Care Medicine Specialist
  Temple University Hospital
  Philadelphia, Pennsylvania

  Disclosure: NO DISCLOSURE DATA
• SD

  Simrat Dhaliwal, BS

  Medical Student
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• VD

  Venkata Naga Kiran Dintyala, MD

  Sharp Research Team
  Sharp Healthcare
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SF

  Scott Flanders, MD

  Professor of Medicine, Chief Clinical Strategy Officer
  University of Michigan
  Ann Arbor, Michigan

  Disclosure: Agency for Healthcare Research and Quality (Research Grant or Support)Blue Cross Blue Shield of Michigan (Research Grant or Support)
• JF

  Jenny Fung, BS

  Medical Student
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MG

  Massimo Galli, MD

  Investigator
  Dipartimento di Malattie Infettive, Malattie Infettive I- Malattie Infettive III, ASST Fatebenfratelli Sacco Ospedale Luigi Sacco
  Milano, Lombardia, Italy

  Disclosure: Gilead Sciences Inc. (Grant/Research Support, Scientific Research Study Investigator, Advisor or Review Panel member, Other Financial or Material Support, Personal fees)
• 

  Tejal Gandhi, MD

  Clinical Associate Professor of Internal Medicine, Division of Infectious Diseases Medical Director Antimicrobial Stewardship Program
  University of Michigan
  Ann Arbor, Michigan

  Disclosure: Blue Cross Blue Shield of Michigan : Grant/Research Support (Status: Ongoing)
• MG

  Matthew Geriak, PharmD

  Clinical Associate Professor
  Sharp Hospital
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MG

  Mitra Ghafourian, MD

  Sharp Research Team
  Sharp Healthcare
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AG

  Ane Josune Goikoetxea, MD

  Investigator
  Hospital Universitario de Cruces
  Bizkaia, Pais Vasco, Spain

  Disclosure: Gilead Sciences Inc. (Scientific Research Study Investigator)
• RG

  Robert Gottlieb, MD

  Practicing Physician
  Baylor University Medical Center
  Dallas, Texas

  Disclosure: NO DISCLOSURE DATA
• KG

  Kris Greenwood, PhD

  Sharp Research Team
  Sharp Healthcare
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• PG

  Prabhjot Grewal, MD

  Medical Resident
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MH

  Mackenzie Habib, n/a

  Sharp Research Team
  Sharp Healthcare
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• FH

  Fadi Haddad, MD

  Attending Physician
  Sharp Hospital
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JH

  Jessica Hotelling, MD

  Medical Resident
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• RH

  Robert Hyland, MD

  Sr Director, Virology Clinical Research
  Gilead Sciences Inc.
  Foster City, California

  Disclosure: Gilead Sciences Inc. (Employee, Shareholder)
• RJ

  Robin Jacob, MD

  Medical Resident
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MJ

  Mamta Jain, MD

  Associate Professor
  UT Southwestern
  Dallas, Texas

  Disclosure: Gilead Sciences Inc. (Scientific Research Study Investigator, Research Grant or Support)GlaxoSmithKline (Advisor or Review Panel member)Janssen (Research Grant or Support)Merck (Research Grant or Support)
• AK

  Andreas Kalogeropoulos, MD, MPH, PhD

  Associate Professor of Medicine (Cardiology)
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• NK

  Nikitha Karkala, BS

  Medical Student
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Ravina Kullar, PharmD, MPH, FIDSA

  Infectious Diseases Pharmacist & Epidemiologist
  Expert Stewardship, Inc. Founder, duXsana
  Santa Monica, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Anurag Malani, MD, FIDSA, FSHEA

  Medical Director, Infection Prevention & Antimicrobial Stewardship Programs
  Division of Infectious Diseases, Department of Internal Medicine
  St. Joseph Mercy Health System, Ann Arbor
  Ann Arbor, MI

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• PM

  Prashant Malhotra, MD

  Associate Professor
  Northshore University Hospital, Northwell Health
  Manhasset, New York

  Disclosure: Gilead Sciences Inc. (Scientific Research Study Investigator)
• LM

  Luis Marcos, MD, MPH

  Associate Professor of Medicine, ID fellowship program director
  Medicine / Division of Infectious Disease
  Stony Brook University
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• EM

  Elizabeth McLaughlin, BSN, MS

  Project Manager of HMS
  University of Michigan
  Ann Arbor, Michigan

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AM

  Azad Mojahedi, MD

  Attending Physician
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JM

  Jose Muñoz, MD

  Investigator
  Hospital Clinic de Barcelona
  Barcelona, Andalucia, Spain

  Disclosure: NO DISCLOSURE DATA
• JN

  Jacquelyn Nakamura, BS

  Medical Students
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AO

  Anu Osinusi, MD

  Clinical Research
  Gilead
  Foster City, California

  Disclosure: Gilead Sciences (Employee)
• PP

  Payal Patel, MD, MPH

  Dr.
  University of Michigan
  Ann Arbor, Michigan

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• LP

  Lindsay Petty, MD

  Infectious Disease Assistant Professor
  University of Michigan
  Ann Arbor, Michigan

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• HP

  Hallie Prescott, MD, MSc

  Dr.
  University of Michigan
  Ann Arbor, Michigan

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• DR

  David Ratz, MS

  Statistician
  University of Michigan
  Ann Arbor, Michigan

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SR

  Sahil Rawal, BS

  medical Student
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• PR

  Philip Robinson, MD

  Physician
  Hoag Hospital
  Irvine, California

  Disclosure: NO DISCLOSURE DATA
• DS

  Devi SenGupta, MD

  Sr Director, Clinical Research (MD)
  Clinical Research - HIV
  Gilead Sciences Inc.
  Foster City, California

  Disclosure: NO DISCLOSURE DATA
• DS

  David Shu Cheong Hui, MD

  Investigator
  Chinese University of Hong Kong
  Hong Kong, Hong Kong

  Disclosure: Gilead Sciences Inc. (Scientific Research Study Investigator)
• CS

  Christoph Spinner, MD

  MD
  Department of Medicine II, University Hospital rechts der Isar, Technical University of Munich, Munich, Germany
  Munich, Bayern, Germany

  Disclosure: AbbVie (Advisor or Review Panel member, Other Financial or Material Support, Travel)Bristol-Myers Squibb (Grant/Research Support, Advisor or Review Panel member, Other Financial or Material Support, Travel)Gilead Sciences Inc. (Grant/Research Support, Scientific Research Study Investigator, Advisor or Review Panel member, Other Financial or Material Support, Travel)Janssen (Grant/Research Support, Advisor or Review Panel member, Other Financial or Material Support, Travel)MSD (Grant/Research Support, Advisor or Review Panel member, Other Financial or Material Support, Travel)Viiv Healthcare (Grant/Research Support, Advisor or Review Panel member, Other Financial or Material Support, Travel)
• OT

  Owen Tak-Yin Tsang, MD

  Investigator
  Princess Margaret Hospital
  Hong Kong, Hong Kong

  Disclosure: NO DISCLOSURE DATA
• KT

  Karen Tashima, MD

  Clinical Research Site Leader
  The Miriam Hospital
  Providence, Rhode Island

  Disclosure: NO DISCLOSURE DATA
• ST

  Stella Tsui, BS

  Medical Student
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• EV

  Elena Vendrame, MD

  Director, Virology Clinical Research
  Gilead Sciences Inc.
  Foster City, California

  Disclosure: NO DISCLOSURE DATA
• AV

  Anuja Vyas, MD

  Sharp Research Team
  Sharp Healthcare
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• HW

  Hongyuan Wang, PhD

  Manager, Biostatistics
  Gilead Sciences Inc.
  Foster City, California

  Disclosure: Gilead Sciences Inc. (Employee, Shareholder)
• LY

  Louis Yi Ann Chai, MD

  Practicing Physician
  National University Hospital, National University Health System
  Singapore, Singapore

  Disclosure: Gilead Sciences Inc. (Scientific Research Study Investigator)
• JY

  Jeanwoo Yoo, MD

  Medical Resident
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• LZ

  Lijie Zhong, PhD

  Executive Director, Biostatistics
  Gilead Sciences
  Foster City, California

  Disclosure: Gilead Sciences Inc. (Employee, Shareholder)

Presenting Author(s)

• 

  George Diaz, MD

  Section Chief, Infectious Diseases
  Providence Regional Medical Center Everett
  Everett, WA

  Disclosure: Gilead Sciences Inc. : Scientific Research Study Investigator; Lexicon Pharmaceuticals : Consultant (Status: Ongoing); Regeneron : Scientific Research Study Investigator

  Slides Slides and Audio
• 

  Francisco Marty, MD

  Associate Professor
  Infectious Diseases
  Brigham and Women's Hospital
  Boston, MA

  Disclosure: Allovir (Consultant)Amplyx (Consultant)Ansun (Scientific Research Study Investigator)Avir (Consultant)Cidara (Scientific Research Study Investigator)F2G (Consultant, Scientific Research Study Investigator)Kyorin (Consultant)Merck (Consultant, Grant/Research Support, Scientific Research Study Investigator)New England Journal of Medicine (Other Financial or Material Support, Honorarium for Video)Regeneron (Consultant, Scientific Research Study Investigator)ReViral (Consultant)Scynexis (Scientific Research Study Investigator)Symbio (Consultant)Takeda (Scientific Research Study Investigator)United Medical (Consultant)WHISCON (Scientific Research Study Investigator)

  Slides Slides and Audio
• 

  Aikaterini Papamanoli, MD

  Infectious Diseases Fellow
  Department of Medicine
  Stony Brook University Hospital
  Stony Brook, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  George Sakoulas, MD

  Associate Professor
  University of California San Diego/Sharp Healthcare
  San Diego, CA

  Disclosure: Octapharma (Grant/Research Support, Scientific Research Study Investigator)

  Slides Slides and Audio
• 

  Joowhan Sung, MD

  Hospitalist
  MedStar Southern Maryland Hospital
  Clinton, MD

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Valerie Vaughn, MD, MSc

  Director of Hospital Medicine Research
  Internal Medicine
  University of Utah School of Medicine
  Salt Lake City, UT

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio

Presentations:

• use of Intravenous Immunoglobulin Therapy Reduces Progression to Mechanical Ventilation in COVID‑19 Patients with Moderate to Severe Hypoxia
  George Sakoulas, MD – University of California San Diego/Sharp Healthcare; Matthew Geriak, PharmD – Sharp Hospital; Ravina Kullar, PharmD, MPH, FIDSA – Expert Stewardship, Inc. Founder, duXsana; Kris Greenwood, PhD – Sharp Healthcare; Mackenzie Habib, n/a – Sharp Healthcare; Anuja Vyas, MD – Sharp Healthcare; Mitra Ghafourian, MD – Sharp Healthcare; Venkata Naga Kiran Dintyala, MD – Sharp Healthcare; Fadi Haddad, MD – Sharp Hospital
• Remdesivir vs Standard Care in Patients with Moderate covid-19
  Francisco M. Marty, MD – Brigham and Women's Hospital; Prashant Malhotra, MD – Northshore University Hospital, Northwell Health; Robert L. Gottlieb, MD – Baylor University Medical Center; Karen T. Tashima, MD – The Miriam Hospital; Massimo Galli, MD – Dipartimento di Malattie Infettive, Malattie Infettive I- Malattie Infettive III, ASST Fatebenfratelli Sacco Ospedale Luigi Sacco; Louis Yi Ann Chai, MD – National University Hospital, National University Health System; Devi SenGupta, MD – Gilead Sciences Inc.; Robert H. Hyland, MD – Gilead Sciences Inc.; Hongyuan Wang, PhD – Gilead Sciences Inc.; Lijie Zhong, PhD – Gilead Sciences; Huyen Cao, MD – Gilead Sciences Inc.; Anand Chokkalingam, PhD – Gilead; Anu Osinusi, MD – Gilead; Diana M. Brainard, MD – Gilead Sciences Inc.; Michael Brown, MD – University College Hospital; Ane Josune Goikoetxea, MD – Hospital Universitario de Cruces; Mamta Jain, MD – UT Southwestern; David Shu Cheong Hui, MD – Chinese University of Hong Kong; Enos Bernasconi, MD – Servizio Malattie infettive, Ente Ospedaliero Cantonale, Ospedale; Christoph Spinner, MD – Department of Medicine II, University Hospital rechts der Isar, Technical University of Munich, Munich, Germany
• Geographical Disparities in Clinical Outcomes of Severe COVID-19 Patients Treated with Remdesivir
  George Diaz, MD – Providence Regional Medical Center Everett; Jose R. Arribas, MD – Hospital Universitario La Paz; Philip A. Robinson, MD – Hoag Hospital; Anna Maria Cattelan, MD – UOC Malattie Infettive e Tropicali, Azienda Ospedaliera di Padova; Karen T. Tashima, MD – The Miriam Hospital; Owen Tak-Yin Tsang, MD – Princess Margaret Hospital; Yao-Shen Chen, MD – Kaohsiung Veterans General Hospital; Devi SenGupta, MD – Gilead Sciences Inc.; Elena Vendrame, MD – Gilead Sciences Inc.; Christiana Blair, MS – Gilead Sciences Inc.; Anand Chokkalingam, PhD – Gilead; Anu Osinusi, MD – Gilead; Diana M. Brainard, MD – Gilead Sciences Inc.; Bum Sik Chin, MD – National Medical Center; Christoph Spinner, MD – Department of Medicine II, University Hospital rechts der Isar, Technical University of Munich, Munich, Germany; Gerard J. Criner, MD – Temple University Hospital; Jose Muñoz, MD – Hospital Clinic de Barcelona; David Chien Boon Lye, MD – National Centre for Infectious Diseases, Tan Tock Seng Hospital; Robert L. Gottlieb, MD – Baylor University Medical Center
• Empiric Antibiotic Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study
  Valerie Vaughn, MD, MSc – University of Utah School of Medicine; Tejal N. Gandhi, MD – University of Michigan; Lindsay A. Petty, MD – University of Michigan; Payal K. Patel, MD, MPH – University of Michigan; Hallie Prescott, MD, MSc – University of Michigan; Anurag N. Malani, MD, FIDSA, FSHEA – St. Joseph Mercy Health System, Ann Arbor; David Ratz, MS – University of Michigan; Elizabeth McLaughlin, BSN, MS – University of Michigan; Vineet Chopra, MD, MSc – Michigan Medicine; Scott A. Flanders, MD – University of Michigan
• Systemic Anticoagulation Use Is Independently Associated with Lower Mortality in Hospitalized COVID-19 Patients with D-dimer Level Higher Than 5 Mcg/ml
  Joowhan Sung, MD – MedStar Southern Maryland Hospital; Rima Bachour, MD – MedStar Southern Maryland Hospital
• Effect of Early Administration of Systemic Corticosteroids on Outcomes in Patients with COVID-19 Pneumonia
  Aikaterini Papamanoli, MD – Stony Brook University Hospital; Andreas Kalogeropoulos, MD, MPH, PhD – Stony Brook University Hospital; Jenny Fung, BS – Stony Brook University Hospital; Jacquelyn Nakamura, BS – Stony Brook University Hospital; Jeanwoo Yoo, MD – Stony Brook University Hospital; Prabhjot Grewal, MD – Stony Brook University Hospital; Nikitha Karkala, BS – Stony Brook University Hospital; Joshua Abata, BS – Stony Brook University Hospital; Stella T. Tsui, BS – Stony Brook University Hospital; Alexandra Coritsidis, BS – Stony Brook University Hospital; Azad Mojahedi, MD – Stony Brook University Hospital; Robin Jacob, MD – Stony Brook University Hospital; Jessica Hotelling, MD – Stony Brook University Hospital; Simrat Dhaliwal, BS – Stony Brook University Hospital; Sahil Rawal, BS – Stony Brook University Hospital; Luis Marcos, MD, MPH – Stony Brook University